Ubs Group Ag En V Veno Medical Corp Transaction History
Ubs Group Ag
- $527 Billion
- Q4 2024
A detailed history of Ubs Group Ag transactions in En V Veno Medical Corp stock. As of the latest transaction made, Ubs Group Ag holds 6,060 shares of NVNO stock, worth $22,300. This represents 0.0% of its overall portfolio holdings.
Number of Shares
6,060
Previous 16,626
63.55%
Holding current value
$22,300
Previous $55,000
69.09%
% of portfolio
0.0%
Previous 0.0%
Shares
12 transactions
Others Institutions Holding NVNO
# of Institutions
40Shares Held
4.66MCall Options Held
76KPut Options Held
100-
Kingdon Capital Management, L.L.C. New York, NY859KShares$3.16 Million0.41% of portfolio
-
Nantahala Capital Management, LLC New Canaan, CT597KShares$2.2 Million0.09% of portfolio
-
Vanguard Group Inc Valley Forge, PA589KShares$2.17 Million0.0% of portfolio
-
Act Capital Management, LLC Wayne, PA401KShares$1.48 Million3.48% of portfolio
-
Altium Capital Management LP New York, NY310KShares$1.14 Million0.3% of portfolio
About enVVeno Medical Corp
- Ticker NVNO
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 9,469,850
- Market Cap $34.8M
- Description
- enVVeno Medical Corporation, a medical device company, focuses on the development of various bioprosthetic tissue-based solutions to enhance the standard of care in the treatment of venous diseases. The company's lead product is the VenoValve, a surgical implant being developed for the treatment of severe deep venous chronic venous insufficiency...